Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KOD |
---|---|---|
09:32 ET | 52923 | 2.6 |
09:36 ET | 400 | 2.61 |
09:38 ET | 936 | 2.62 |
09:41 ET | 400 | 2.63 |
09:43 ET | 500 | 2.65 |
09:45 ET | 850 | 2.65 |
09:48 ET | 1000 | 2.655 |
09:52 ET | 100 | 2.6638 |
09:54 ET | 600 | 2.65 |
09:56 ET | 300 | 2.63 |
09:57 ET | 400 | 2.61 |
09:59 ET | 100 | 2.6 |
10:01 ET | 766 | 2.61 |
10:10 ET | 100 | 2.59 |
10:12 ET | 100 | 2.608 |
10:15 ET | 2877 | 2.64 |
10:17 ET | 200 | 2.6397 |
10:21 ET | 100 | 2.64 |
10:28 ET | 245 | 2.635 |
10:30 ET | 404 | 2.64 |
10:32 ET | 832 | 2.644 |
10:33 ET | 225 | 2.647 |
10:37 ET | 131 | 2.64 |
10:48 ET | 100 | 2.65 |
10:50 ET | 202 | 2.65 |
10:57 ET | 1200 | 2.65 |
11:06 ET | 452 | 2.66 |
11:09 ET | 108 | 2.6401 |
11:11 ET | 4352 | 2.6345 |
11:15 ET | 200 | 2.64 |
11:54 ET | 100 | 2.63 |
12:02 ET | 200 | 2.64 |
12:05 ET | 100 | 2.64 |
12:09 ET | 5552 | 2.64 |
12:12 ET | 5637 | 2.65 |
12:14 ET | 8492 | 2.655 |
12:16 ET | 8868 | 2.63 |
12:20 ET | 673 | 2.63 |
12:23 ET | 100 | 2.64 |
12:25 ET | 200 | 2.635 |
12:30 ET | 100 | 2.635 |
12:32 ET | 100 | 2.635 |
12:34 ET | 10479 | 2.64 |
12:36 ET | 200 | 2.64 |
01:17 ET | 100 | 2.64 |
01:19 ET | 400 | 2.645 |
01:26 ET | 168 | 2.6401 |
01:37 ET | 100 | 2.64 |
01:46 ET | 100 | 2.645 |
01:48 ET | 916 | 2.65 |
01:50 ET | 100 | 2.65 |
02:00 ET | 1172 | 2.655 |
02:06 ET | 100 | 2.6502 |
02:08 ET | 100 | 2.655 |
02:15 ET | 100 | 2.66 |
02:20 ET | 478 | 2.655 |
02:22 ET | 100 | 2.65 |
02:24 ET | 100 | 2.66 |
02:26 ET | 100 | 2.65 |
02:27 ET | 400 | 2.66 |
02:29 ET | 100 | 2.655 |
02:38 ET | 2328 | 2.63 |
02:44 ET | 1681 | 2.63 |
02:47 ET | 100 | 2.63 |
02:49 ET | 100 | 2.63 |
02:54 ET | 100 | 2.63 |
02:56 ET | 2041 | 2.63 |
03:00 ET | 1143 | 2.63 |
03:03 ET | 100 | 2.63 |
03:07 ET | 200 | 2.635 |
03:09 ET | 400 | 2.635 |
03:12 ET | 100 | 2.63 |
03:14 ET | 200 | 2.63 |
03:16 ET | 100 | 2.635 |
03:18 ET | 200 | 2.63 |
03:20 ET | 100 | 2.63 |
03:23 ET | 300 | 2.63 |
03:25 ET | 200 | 2.638 |
03:27 ET | 100 | 2.64 |
03:30 ET | 600 | 2.64 |
03:32 ET | 200 | 2.64 |
03:34 ET | 270 | 2.643 |
03:38 ET | 100 | 2.645 |
03:41 ET | 201 | 2.64 |
03:43 ET | 107 | 2.63 |
03:48 ET | 673 | 2.63 |
03:50 ET | 200 | 2.635 |
03:52 ET | 600 | 2.64 |
03:54 ET | 2000 | 2.64 |
03:56 ET | 300 | 2.645 |
03:57 ET | 600 | 2.64 |
03:59 ET | 1700 | 2.64 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kodiak Sciences Inc | 138.7M | -0.6x | --- |
Acumen Pharmaceuticals Inc | 138.8M | -2.2x | --- |
Cytodyn Inc | 139.1M | -2.5x | --- |
Elevation Oncology Inc | 139.9M | -2.5x | --- |
Atossa Therapeutics Inc | 142.1M | -4.8x | --- |
Yubo International Biotech Ltd | 137.8M | -109.6x | --- |
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $138.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.38 |
EPS | $-4.44 |
Book Value | $5.06 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.